A Phase 1 Study to Examine the Pharmacodynamics of Different AZD1722 Formulations
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The study is designed to evaluate safety, tolerability, pharmacodynamics and pharmacokinetics
of different formulations of AZD1722 in healthy male and female subjects taking Omeprazole.